share_log

Institutional Investors in New Horizon Health Limited (HKG:6606) Lost 8.1% Last Week but Have Reaped the Benefits of Longer-term Growth

先週、ニューホライズンヘルスリミテッド(HKG:6606)の機関投資家は8.1%の損失を被りましたが、長期的な成長の恩恵を受けています。

Simply Wall St ·  2023/12/01 18:32

Key Insights

  • Given the large stake in the stock by institutions, New Horizon Health's stock price might be vulnerable to their trading decisions
  • The top 9 shareholders own 51% of the company
  • Insider ownership in New Horizon Health is 17%

To get a sense of who is truly in control of New Horizon Health Limited (HKG:6606), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are institutions with 46% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

Losing money on investments is something no shareholder enjoys, least of all institutional investors who saw their holdings value drop by 8.1% last week. However, the 14% one-year returns may have helped alleviate their overall losses. We would assume however, that they would be on the lookout for weakness in the future.

Let's delve deeper into each type of owner of New Horizon Health, beginning with the chart below.

View our latest analysis for New Horizon Health

ownership-breakdown
SEHK:6606 Ownership Breakdown December 1st 2023

What Does The Institutional Ownership Tell Us About New Horizon Health?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

We can see that New Horizon Health does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of New Horizon Health, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
SEHK:6606 Earnings and Revenue Growth December 1st 2023

We note that hedge funds don't have a meaningful investment in New Horizon Health. Our data suggests that Yiyou Chen, who is also the company's Chief Scientific Officer, holds the most number of shares at 8.1%. When an insider holds a sizeable amount of a company's stock, investors consider it as a positive sign because it suggests that insiders are willing to have their wealth tied up in the future of the company. Qiming Weichuang Venture Capital Management (Shanghai) Company Limited is the second largest shareholder owning 8.0% of common stock, and Invesco Ltd. holds about 7.2% of the company stock. Furthermore, CEO Yeqing Zhu is the owner of 3.4% of the company's shares.

On further inspection, we found that more than half the company's shares are owned by the top 9 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Insider Ownership Of New Horizon Health

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our information suggests that insiders maintain a significant holding in New Horizon Health Limited. Insiders own HK$1.7b worth of shares in the HK$10b company. That's quite meaningful. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling.

General Public Ownership

With a 19% ownership, the general public, mostly comprising of individual investors, have some degree of sway over New Horizon Health. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Private Equity Ownership

With a stake of 8.0%, private equity firms could influence the New Horizon Health board. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.

Private Company Ownership

Our data indicates that Private Companies hold 7.9%, of the company's shares. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For instance, we've identified 2 warning signs for New Horizon Health (1 is significant) that you should be aware of.

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする